These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30793560)

  • 21. Cardiac pathology in spinal muscular atrophy: a systematic review.
    Wijngaarde CA; Blank AC; Stam M; Wadman RI; van den Berg LH; van der Pol WL
    Orphanet J Rare Dis; 2017 Apr; 12(1):67. PubMed ID: 28399889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinal muscular atrophy - insights and challenges in the treatment era.
    Mercuri E; Pera MC; Scoto M; Finkel R; Muntoni F
    Nat Rev Neurol; 2020 Dec; 16(12):706-715. PubMed ID: 33057172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type I spinal muscular atrophy can mimic sensory-motor axonal neuropathy.
    Anagnostou E; Miller SP; Guiot MC; Karpati G; Simard L; Dilenge ME; Shevell MI
    J Child Neurol; 2005 Feb; 20(2):147-50. PubMed ID: 15794183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina.
    Medrano S; Monges S; Gravina LP; Alías L; Mozzoni J; Aráoz HV; Bernal S; Moresco A; Chertkoff L; Tizzano E
    Eur J Paediatr Neurol; 2016 Nov; 20(6):910-917. PubMed ID: 27510309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compound heterozygous mutation in two unrelated cases of Chinese spinal muscular atrophy patients.
    Qu YJ; Song F; Yang YL; Jin YW; Bai JL
    Chin Med J (Engl); 2011 Feb; 124(3):385-9. PubMed ID: 21362338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel.
    Basel-Vanagaite L; Taub E; Drasinover V; Magal N; Brudner A; Zlotogora J; Shohat M
    Genet Test; 2008 Mar; 12(1):53-6. PubMed ID: 18298318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time Is Motor Neuron: Therapeutic Window and Its Correlation with Pathogenetic Mechanisms in Spinal Muscular Atrophy.
    Govoni A; Gagliardi D; Comi GP; Corti S
    Mol Neurobiol; 2018 Aug; 55(8):6307-6318. PubMed ID: 29294245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double trouble: spinal muscular atrophy type II and seropositive myasthenia gravis in the same patient.
    Jokela M; Udd B; Päivärinta M
    Neuromuscul Disord; 2012 Feb; 22(2):129-30. PubMed ID: 21862330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal muscular atrophies.
    Darras BT
    Pediatr Clin North Am; 2015 Jun; 62(3):743-66. PubMed ID: 26022173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migrating atelectasis in Werdnig-Hoffmann disease: pulmonary manifestations in two cases of spinal muscular atrophy type 1.
    Leistikow EA; Jones NE; Josephson KD; de Sierra TM; Costakos DT; Sprague D; Gorch DH; Asonye UO
    Pediatr Pulmonol; 1999 Aug; 28(2):149-53. PubMed ID: 10423316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Werdnig-Hoffmann disease and chronic distal spinal muscular atrophy with apparent autosomal dominant inheritance.
    Boylan KB; Cornblath DR
    Ann Neurol; 1992 Sep; 32(3):404-7. PubMed ID: 1416812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raising obstetricians' awareness of spinal muscular atrophy: towards early detection and reproductive planning.
    Parra J; Tizzano EF
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2555-8. PubMed ID: 22712688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congenital segmental spinal muscular atrophy: a case report.
    Savaş T; Erol I; Özkale Y; Saygi S
    J Child Neurol; 2015 Mar; 30(4):509-12. PubMed ID: 25300987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal muscular atrophy: a time for screening.
    Prior TW
    Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Segmental Spinal Muscular Atrophy Localised to the Lower Limbs: First case from Oman.
    Koul R; Al-Futaisi A; Al-Thihli K; Bruwer Z; Scott P
    Sultan Qaboos Univ Med J; 2017 Aug; 17(3):e355-e357. PubMed ID: 29062563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN gene.
    Lohkamp LN; von Au K; Goebel HH; Kress W; Grieben U; Drossel K; Garbes L; Wirth B; Heppner FL; Stenzel W
    J Child Neurol; 2014 Feb; 29(2):254-9. PubMed ID: 24334346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal Muscular Atrophy Treatments, Newborn Screening, and the Creation of a Neurogenetics Urgency.
    Butterfield RJ
    Semin Pediatr Neurol; 2021 Jul; 38():100899. PubMed ID: 34183144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing a Global Expanded Access Program (EAP) for Infantile-Onset Spinal Muscular Atrophy (Type I): Understanding the Imperative, Impact and Challenges.
    Yong J; Moffett M; Lucas S
    J Neuromuscul Dis; 2019; 6(2):227-231. PubMed ID: 31127730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.